|
Market Closed -
Nasdaq
04:00:00 15/07/2026 HKT
|
5-day change | 1st Jan Change | ||
| 31.49 USD | +0.03% |
|
-.--% | +34.92% |
| 08-03 | CDP targets new defense acquisitions after T-Defence deal - sources | RE |
| 08-03 | CDP's new chapter, a push for global companies | AN |
| Market Cap | 3.85B 3.33B 3.13B 2.85B 5.36B 369B 5.43B 36.75B 14.4B 185B 14.47B 14.16B 615B | P/E 2024 |
15.9x | P/E 2025 | 13.9x |
|---|---|---|---|---|---|
| Enterprise Value | 3.15B 2.72B 2.56B 2.33B 4.37B 302B 4.44B 30.01B 11.76B 151B 11.82B 11.56B 503B | EV / Sales 2024 |
4.02x | EV / Sales 2025 | 3.67x |
| Free-Float |
99.94% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Catalyst Pharmaceuticals, Inc.
| 1 day | +0.03% | ||
| 3 months | +0.83% | ||
| 6 months | +29.64% | ||
| Current year | +34.92% |
| Current year | 22.13 |  | 32.56 |
| 1 year | 19.05 | | 32.56 |
| 3 years | 11.55 | | 32.56 |
| 5 years | 4.81 | | 32.56 |
| 10 years | 0.94 | | 32.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Daly
CEO | Chief Executive Officer | 65 | 01/01/2024 |
Michael Kalb
DFI | Director of Finance/CFO | 55 | 01/01/2024 |
William Andrews
CTO | Chief Tech/Sci/R&D Officer | 62 | 01/06/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 48 | 15/07/2026 | |
Massimo Marin
BRD | Director/Board Member | - | 15/07/2026 |
Enrica Dogali
BRD | Director/Board Member | - | 15/07/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 15/7/26 | Issuer sale | Director | -63,583 | 0.0519% | ||
| 15/7/26 | Issuer sale | Director | -130,857 | 0.1069% | ||
| 15/7/26 | Issuer sale | Executive/Senior Manager | -1,051,183 | 0.8587% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.03% | -.--% | +55.66% | +118.07% | 3.85B | |
| +0.53% | +1.66% | +41.18% | -0.27% | 80.91B | |
| -1.10% | -4.85% | -3.14% | +29.15% | 50.13B | |
| +0.41% | -1.62% | +13.35% | +167.73% | 47.97B | |
| +5.49% | +20.25% | -26.17% | -37.62% | 53.62B | |
| +1.63% | +4.25% | +56.39% | -18.61% | 31.41B | |
| -2.33% | +3.95% | +124.14% | -38.04% | 25.14B | |
| -0.02% | +1.98% | +45.40% | +92.80% | 25.03B | |
| +1.66% | +2.83% | +0.51% | +215.41% | 21.45B | |
| +0.77% | +4.99% | +67.14% | +127.58% | 16.93B | |
| Average | +6.39% | +2.36% | +37.45% | +65.62% | 35.64B | |
| Weighted average by Cap. | +4.97% | +2.40% | +27.50% | +43.45% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 492M 425M 400M 363M 683M 47.11B 693M 4.69B 1.84B 23.56B 1.85B 1.81B 78.49B | 589M 509M 479M 435M 818M 56.43B 830M 5.61B 2.2B 28.22B 2.21B 2.16B 94.01B |
| Net income | 164M 142M 133M 121M 228M 15.7B 231M 1.56B 612M 7.85B 615M 602M 26.16B | 214M 185M 174M 158M 298M 20.54B 302M 2.04B 801M 10.27B 805M 787M 34.21B |
| Net Debt | -514M -444M -418M -380M -715M -49.28B -725M -4.9B -1.92B -24.65B -1.93B -1.89B -82.1B | -706M -610M -574M -522M -981M -67.68B -996M -6.73B -2.64B -33.85B -2.65B -2.59B -113B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- CPRX Stock
Select your edition
All financial news and data tailored to specific country editions
